Losartan

Breastfeeding
  • TRADE NAME: Cozaar (Merck); Hyzaar (Merck)
  • INDICATIONS: Hypertension
  • CLASS: Angiotensin II receptor blocker, Antihypertensive
  • HALF-LIFE: 2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Rifampin

PREGNANCY CATEGORY: D

category C in first trimester; category D in second and third trimesters

Hyzaar is losartan and hydrochlorothiazide

Our database has 54 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile

or Take a FREE TRIAL

SKIN
HAIR
NAILS
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
OTHER
  • Saved Searches
  • Watch Drug

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life Threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric